These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19149690)

  • 1. The potential anti-tumorigenic and anti-metastatic side of the proprotein convertases inhibitors.
    Lahlil R; Calvo F; Khatib AM
    Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):83-91. PubMed ID: 19149690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proprotein convertase inhibition: Paralyzing the cell's master switches.
    Klein-Szanto AJ; Bassi DE
    Biochem Pharmacol; 2017 Sep; 140():8-15. PubMed ID: 28456517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proprotein convertases: Key players in inflammation-related malignancies and metastasis.
    Siegfried G; Descarpentrie J; Evrard S; Khatib AM
    Cancer Lett; 2020 Mar; 473():50-61. PubMed ID: 31899298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential opportunity in the development of new therapeutic agents based on endogenous and exogenous inhibitors of the proprotein convertases.
    Bontemps Y; Scamuffa N; Calvo F; Khatib AM
    Med Res Rev; 2007 Sep; 27(5):631-48. PubMed ID: 17019676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the myosin heavy polypeptide 9 as a downstream effector of the proprotein convertases in the human colon carcinoma HT-29 cells.
    Scamuffa N; Metrakos P; Calvo F; Khatib AM
    Methods Mol Biol; 2011; 768():207-15. PubMed ID: 21805244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proprotein convertases - family of serine proteases with a broad spectrum of physiological functions].
    Małuch I; Walewska A; Sikorska E; Prahl A
    Postepy Biochem; 2016; 62(4):472-481. PubMed ID: 28132449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endo/exo-proteolysis in neoplastic progression and metastasis.
    Khatib AM; Bassi D; Siegfried G; Klein-Szanto AJ; Ouafik L
    J Mol Med (Berl); 2005 Nov; 83(11):856-64. PubMed ID: 16133424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy.
    Khatib AM; Siegfried G; Chrétien M; Metrakos P; Seidah NG
    Am J Pathol; 2002 Jun; 160(6):1921-35. PubMed ID: 12057895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proprotein convertase inhibitory activities of flavonoids isolated from Oroxylum indicum.
    Majumdar S; Mohanta BC; Chowdhury DR; Banik R; Dinda B; Basak A
    Curr Med Chem; 2010; 17(19):2049-58. PubMed ID: 20423311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of subtilisin-like convertases in cadherin processing or the conundrum to stall cadherin function by convertase inhibitors in cancer therapy.
    Müller EJ; Caldelari R; Posthaus H
    J Mol Histol; 2004 Mar; 35(3):263-75. PubMed ID: 15339046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proprotein convertases: "master switches" in the regulation of tumor growth and progression.
    Bassi DE; Fu J; Lopez de Cicco R; Klein-Szanto AJ
    Mol Carcinog; 2005 Nov; 44(3):151-61. PubMed ID: 16167351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of proprotein convertases.
    Basak A
    J Mol Med (Berl); 2005 Nov; 83(11):844-55. PubMed ID: 16215768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proprotein convertases are potential targets in the treatment of dyslipidemia.
    Seidah NG; Prat A
    J Mol Med (Berl); 2007 Jul; 85(7):685-96. PubMed ID: 17351764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of liver colorectal metastasis by the serpin Spn4A a naturally occurring inhibitor of the constitutive secretory proprotein convertases.
    Sfaxi F; Scamuffa N; Lalou C; Ma J; Metrakos P; Siegfried G; Ragg H; Bikfalvi A; Calvo F; Khatib AM
    Oncotarget; 2014 Jun; 5(12):4195-210. PubMed ID: 24961901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting back on pro-protein convertases: the latest approaches to pharmacological inhibition.
    Fugère M; Day R
    Trends Pharmacol Sci; 2005 Jun; 26(6):294-301. PubMed ID: 15925704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proprotein convertases furin and PACE4 play a significant role in tumor progression.
    Bassi DE; Mahloogi H; Klein-Szanto AJ
    Mol Carcinog; 2000 Jun; 28(2):63-9. PubMed ID: 10900462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor screening of proprotein convertases using positional scanning libraries.
    Lindberg I; Appel JR
    Methods Mol Biol; 2011; 768():155-66. PubMed ID: 21805241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Roles of Protease Inhibitors in Cancer Progression.
    Yang P; Li ZY; Li HQ
    Asian Pac J Cancer Prev; 2015; 16(18):8047-52. PubMed ID: 26745037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis.
    Stawowy P; Meyborg H; Stibenz D; Borges Pereira Stawowy N; Roser M; Thanabalasingam U; Veinot JP; Chrétien M; Seidah NG; Fleck E; Graf K
    Circulation; 2005 May; 111(21):2820-7. PubMed ID: 15911696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proprotein convertases, 20 years later.
    Seidah NG
    Methods Mol Biol; 2011; 768():23-57. PubMed ID: 21805237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.